Historical shareholding details of Applied Finance Valuation 50 holdings in Regeneron Pharmaceuticals, Inc. (REGN)

Monthly changes of Applied Finance Valuation 50 shareholding in Regeneron Pharmaceuticals, Inc. over the previous months

Month	Name	Total no. shares held	Percent Holding
Month	Name	Total no. shares held	Percent Holding
Jun 30, 2025	Applied Finance Valuation 50	26,922	0.03%

Mar 31, 2025	Applied Finance Valuation 50	25,509	0.02%

Dec 31, 2024	Applied Finance Valuation 50	36,730	0.03%

Sep 30, 2024	Applied Finance Valuation 50	29,546	0.03%

Jun 30, 2024	Applied Finance Valuation 50	27,366	0.02%

Mar 31, 2024	Applied Finance Valuation 50	24,815	0.02%

Dec 31, 2023	Applied Finance Valuation 50	38,523	0.04%

Sep 30, 2023	Applied Finance Valuation 50	37,620	0.03%

Jun 30, 2023	Applied Finance Valuation 50	44,636	0.04%

Mar 31, 2023	Applied Finance Valuation 50	37,926	0.03%